Nessan Bermingham
11Patents
3h-index
9Co-inventors
53Inventor score
Filing activity: Jun 1, 2000 → May 9, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7053200B1 | Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation | Emerging Cross-Sectional Technologies | 16 | Expired |
| US7470673B2 | Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation | Chemistry; Metallurgy | 6 | Expired |
| US6838444B1 | Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation | Chemistry; Metallurgy | 5 | Expired |
| US11479575B2 | RNA-editing oligonucleotides and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US11453878B2 | RNA-editing oligonucleotides and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US7442688B2 | Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation | Chemistry; Metallurgy | 2 | Expired |
| US11408000B2 | Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity | Chemistry; Metallurgy | 1 | Active |
| US12173285B2 | RNA-editing oligonucleotides and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12297432B2 | Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity | Chemistry; Metallurgy | 0 | Active |
| US12152050B2 | RNA-editing oligonucleotides and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12031131B2 | RNA-editing oligonucleotides and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.